COPD Devices Market Growth, Trends, Size and Share by 2030
市场洞察和分析师观点：
慢性阻塞性肺病是一种长期疾病，会导致肺部炎症、损害肺组织并导致肺部狭窄呼吸道，导致呼吸困难。随着开发用于治疗慢性阻塞性肺病的智能吸入器的研发活动不断增加、慢性阻塞性肺病病例数量的增加以及政府对慢性阻塞性肺病治疗的支持不断增加，慢性阻塞性肺病设备的市场规模正在扩大。此外，市场参与者提供的先进产品进一步推动了市场的增长。例如，2021年6月，Glenmark Pharma在英国推出了用于治疗慢性阻塞性肺病的噻托溴铵干粉吸入器。
增长动力和挑战：
慢性阻塞性肺病是一种慢性肺部疾病，会引起肺部炎症，导致肺部气流阻塞。慢性阻塞性肺病的症状包括呼吸困难、产生粘液（痰）、咳嗽和喘息。它通常是由长期接触刺激性气体或颗粒物引起的，最常见的是香烟烟雾。患有慢性阻塞性肺病的人患肺癌、心脏病和各种其他疾病的风险增加。根据美国肺脏协会的数据，慢性阻塞性肺病是美国的首要死因，到 2022 年，超过 1200 万美国人被诊断患有这些疾病。根据同一来源，2019 年至 2020 年期间，全球约有 850 万成年人被诊断患有慢性阻塞性肺病。根据世界卫生组织 (WHO) 的数据，2021 年，慢性阻塞性肺病 (COPD) 成为全球第三大死因。 COPD的高死亡率是由于急性加重导致患者呼吸肌衰竭，导致患者丧失自主呼吸能力；结果，患者死于全身感染和窒息。此外，根据阻塞性肺病负担 (BOLD) 报告，到 2020 年，预计未来 40 年全球因慢性阻塞性肺病 (COPD) 导致的死亡率将上升，预计到 2060 年每年将达到约 540 万人。全球慢性阻塞性肺病正在推动慢性阻塞性肺病设备市场的增长。
报告细分和范围：
慢性阻塞性肺病设备市场根据产品类型、年龄组、分销渠道和地理位置进行细分。慢性阻塞性肺病设备市场按类型分为吸入器和雾化器。 COPD 设备市场按年龄组划分为 20-40 岁、41-65 岁、66-80 岁和 85 岁以上。慢性阻塞性肺病设备市场按分销渠道分为医院药房、零售药房和在线药房。根据地理位置，COPD设备市场分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、意大利、西班牙和欧洲其他地区）、亚太地区（中国、澳大利亚、日本、印度） 、韩国以及亚太地区其他地区）、中东和非洲（阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷以及南美洲和中美洲其他地区） ).
细分分析：
COPD 设备市场按产品类型分为吸入器和雾化器。 2022年，吸入器细分市场占据更大的市场份额，预计在预测期内将录得更高的复合年增长率。定量吸入器（MDI）和干粉吸入器（DPI）是用于治疗慢性阻塞性肺病的两种主要类型的吸入器。与其他提供一股药物的吸入器不同，这些吸入器以干粉形式容纳药物。患者需要快速深呼吸以使药物进入肺部。干粉吸入器是临床上合适且具有成本效益的替代品。定量吸入器 (MDI) 是手持式加压吸入器系统，可直接向患者气道提供小而精确剂量的药物。 MDI 设备包括阀门和执行器，有助于通过推进剂以精确尺寸分布的颗粒向患者持续输送精确剂量的药物。这些吸入器需要气体推进剂的蒸气压能够在罐内 40 至 70 psi 的温度下液化。这些用于药物吸入的计量吸入器中使用的燃料必须经过食品和药物管理局的认证。它应该意味着当前的良好生产规范 (cGMP) 吸入级具有高纯度水平。
慢性阻塞性肺病设备市场，按产品类型 - 2022 年和 2030 年
区域分析：
根据地理位置，慢性阻塞性肺病设备市场分为北美、欧洲、亚太地区、中东和非洲以及南美和非洲中美洲。北美是全球慢性阻塞性肺病设备市场增长的最大贡献者。此外，预计亚太地区在预测期内将创下全球慢性阻塞性肺病设备市场的最高复合年增长率。该市场的未来增长可能归因于呼吸系统疾病患病率的增加。此外，慢性阻塞性肺病（COPD）是美国的主要健康负担。慢性阻塞性肺病是由肺部气流阻塞引起的，可导致慢性炎症性肺部疾病。吸烟是美国慢性阻塞性肺病的主要原因之一。美国对吸烟日益增长的偏好正在推动慢性阻塞性肺病设备市场的增长。根据美国疾病控制与预防中心 (CDC) 的数据，美国约有 1,480 万成年人患有慢性阻塞性肺病。
此外，根据社区生活管理局的数据，美国 65 岁及以上的人口有 5,410 万占总人口的16%，预计到2040年将达到21.6%。老年人极易患慢性呼吸道疾病。因此，预计老年人口的增加也将在预测期内增加对呼吸吸入器的需求。此外，有利的报销政策预计将为该地区 COPD 设备市场的增长创造多个机会。
行业发展和未来机遇：
以下列出了 COPD 设备市场主要参与者的各种计划：
2022年4月，葛兰素史克制药有限公司在印度推出Trelegy Ellipta（糠酸氟替卡松/umeclidinium/vilanterol）。这是第一个针对慢性阻塞性肺病患者每日一次的单吸入器三联疗法 (SITT)。该产品还获得印度药品监管总局 (DCGI) 批准，可将 Trelegy Ellipta 用作维持治疗，用于预防和缓解 18 岁及以上患者与 COPD 相关的症状。竞争格局和主要公司：
一些COPD 设备市场的知名参与者包括阿斯利康 (AstraZeneca PLC)、Beximco Pharmaceuticals Ltd、Getinge AB、勃林格殷格翰 (Boehringer Ingelheim)、葛兰素史克 (GSK Plc)、美敦力 (Medtronic PLC)、Nephron Pharmaceuticals、诺华 (Novartis AG)、Sunovion Pharmaceuticals Inc 和 Teva Pharmaceuticals。这些公司专注于地域扩张和新产品发布，以满足全球不断增长的消费者需求，并增加其专业产品组合的产品范围。他们的全球业务使他们能够为大量客户提供服务，从而促进市场扩张。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The COPD devices market, by product type, is bifurcated into inhaler and nebulizer. In 2022, the inhaler segment held a larger market share, and it is expected to record a higher CAGR during the forecast period. The COPD devices market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment held the largest market share; moreover, the same segment is expected to record the highest CAGR during the forecast period. Online pharmacies are the fastest-growing distribution channel of the COPD devices market.
The COPD devices market majorly consists of the players such AstraZeneca PLC, Beximco Pharmaceuticals Ltd, Getinge AB, Boehringer Ingelheim, GSK Plc, Medtronic PLC, Nephron Pharmaceuticals, Novartis AG, Sunovion Pharmaceuticals Inc, and Teva Pharmaceuticals
The increasing cases of COPD, and strategic initiatives in COPD devices bolster the COPD devices market size. However, the high cost associated with COPD devices hinders the COPD devices market growth.
Based on geography, the COPD devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global COPD devices market. Asia Pacific is expected to register the highest CAGR in the COPD devices market during 2022–2030.
Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis. In people with COPD, the lungs can get damaged or clogged with phlegm. Symptoms include cough, sometimes with phlegm, difficulty breathing, wheezing and tiredness. Smoking and air pollution are the most common causes of COPD. People with COPD are at higher risk of other health problems.According to Centers for Diseases Control and Prevention (CDC), COPD makes breathing difficult for the 16 million Americans who have this disease. everal inhalation device types are available, including metered-dose inhalers (MDIs), dry-powder inhalers (DPIs), soft mist inhalers (SMIs), and small volume nebulizers (SVNs). Each of these devices has unique attributes to consider when selecting treatment for a specific patient.
The List of Companies - COPD Devices Market
- AstraZeneca PLC
- Beximco Pharmaceuticals Ltd
- Getinge AB
- Boehringer Ingelheim
- GSK Plc
- Medtronic PLC
- Nephron Pharmaceuticals
- Novartis AG
- Sunovion Pharmaceuticals Inc
- Teva Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For